anacaulase-bcdb 8.8 % Topical Gel, 22 GM

RxCUI: 2626751
RxNorm name: anacaulase-bcdb 8.8 % Topical Gel, 22 GM
Display name: anacaulase-bcdb 8.8 % Topical Gel, 22 GM
Full name: anacaulase-bcdb 8.8 % Topical Gel, 22 GM
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:38:49

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761192	Nexobrid	anacaulase-bcdb	351(a)	Disc	2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
NEXOBRID	ANACAULASE-BCDB	Vericel Corporation	1a2f23ad-78ef-43fa-9864-6bd77aac9e57	2025-09-11	Warnings, Adverse reactions	Exact identifier rxcui: 2626751

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
1a2f23ad-78ef-43fa-9864-6bd77aac9e57	anacaulase-bcdb 8.8 % Topical Gel, 22 GM	PSN	10	These highlights do not include all the information needed to use NEXOBRID safely and effectively. See full prescribing information for NEXOBRID. NEXOBRID ® (anacaulase-bcdb), for topical gel Initial U.S. Approval: 2022	20250911
1a2f23ad-78ef-43fa-9864-6bd77aac9e57	22000 MG anacaulase-bcdb 0.088 MG/MG Topical Gel	SCD	10	These highlights do not include all the information needed to use NEXOBRID safely and effectively. See full prescribing information for NEXOBRID. NEXOBRID ® (anacaulase-bcdb), for topical gel Initial U.S. Approval: 2022	20250911
1a2f23ad-78ef-43fa-9864-6bd77aac9e57	anacaulase-bcdb 8.8 % Topical Gel, 22 GM	SY	10	These highlights do not include all the information needed to use NEXOBRID safely and effectively. See full prescribing information for NEXOBRID. NEXOBRID ® (anacaulase-bcdb), for topical gel Initial U.S. Approval: 2022	20250911